Case report: Novel junctional sarcoplasmic reticulum protein 1 intergenic region–anaplastic lymphoma kinase fusion in a patient with lung adenocarcinoma responds to alectinib

Novel anaplastic lymphoma kinase (ALK) fusions are still being discovered in non-small cell lung cancer (NSCLC). Most patients with ALK+ NSCLC respond favorably to ALK tyrosine kinase inhibitors. In this case report, we identified a novel nonreciprocal ALK fusion, namely, junctional sarcoplasmic ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Feng, Xu, Shengyuan, Jiang, Cailing, Kang, Mafei, Usman, Muhammad, Zhu, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577405/
https://www.ncbi.nlm.nih.gov/pubmed/36267987
http://dx.doi.org/10.3389/fonc.2022.1019624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577405/
https://www.ncbi.nlm.nih.gov/pubmed/36267987
http://dx.doi.org/10.3389/fonc.2022.1019624

Ejemplares similares